e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Respiratory infections: miscellanea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Affecting factors of mortality in severe community-acquired pneumonia
T. Yarkin, Z. Karakurt, I. Kilic, P. Pazarli, Y. Dalkilic, O. Sogukpinar, A. A. Oztin, R. Baran (Istanbul, Aydin, Turkey)
Source:
Annual Congress 2005 - Respiratory infections: miscellanea
Session:
Respiratory infections: miscellanea
Session type:
Thematic Poster Session
Number:
4079
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Yarkin, Z. Karakurt, I. Kilic, P. Pazarli, Y. Dalkilic, O. Sogukpinar, A. A. Oztin, R. Baran (Istanbul, Aydin, Turkey). Affecting factors of mortality in severe community-acquired pneumonia. Eur Respir J 2005; 26: Suppl. 49, 4079
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Risk factors of community-acquired pneumonia in children
Source: Eur Respir J 2010; 36: 1221-1222
Year: 2010
Risk factors of paediatric community-acquired pneumonia
Source: Eur Respir J 2011; 37: 724-725
Year: 2011
Analysis of mortality from community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 376s
Year: 2006
Factors affecting short and long-term mortality after community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Analysis of the mortality caused by community-acquired pneumonia in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 544s
Year: 2005
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Treatment failure of community-acquired pneumonia: risk factors and consequences
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018
Factors associated with community-acquired pneumonia in-hospital mortality in Portugal
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
Intrahospital cardiovascular complications in severe community-acquired pneumonia
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Biomarkers as complication predictors in community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Biomarkers and cardiovascular events in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Nosocomial superinfection is one of the principal cause of mortality in severe community-acquired pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Factors influencing in-hospital mortality in community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
Preventing community-acquired pneumonia
Source: International Congress 2019 – Respiratory infections: prevention is better than cure
Year: 2019
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Physical deterioration during hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015
Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1214
Year: 2014
Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1213
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept